VEGFA and asthma: Sook Young Lee and Su‐Mi Chung administered Neovastat (AE‐941) after establishing a mouse model of asthma, and they assessed a decrease in the expression of VEGF and HIF‐2α in lung tissues, concluding that Neovastat significantly attenuated the airway inflammation in asthmatic mice by inhibiting the expression of VEGF and HIF‐2α.